机构

• 上海药物研究所 [8]

采集方式

• OAI收割 [8]

内容类型

• 期刊论文 [7]
• 会议论文 [1]

发表日期

• 2020 [2]
• 2019 [1]
• 2018 [2]
• 2017 [2]
• 2015 [1]

学科主题

筛选

浏览/检索结果: 共8条，第1-8条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Pharmacokinetics, mass balance, and metabolism of [C-14]vicagrel, a novel irreversible P2Y(12) inhibitor in humans 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12 作者:  Zheng, Yuan-dong;  Zhang, Hua;  Zhan, Yan;  Bian, Yi-cong;  Ma, Sheng   |  收藏  |  浏览/下载：29/0  |  提交时间：2021/05/24 vicagrel  [C-14]vicagrel  vicagrel pharmacokinetics  vicagrel metabolism  mass balance  P2Y(12) receptor inhibitor   Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y12inhibitor 期刊论文  OAI收割 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 卷号: 86, 期号: 9, 页码: 1860-1874 作者:     |  收藏  |  浏览/下载：12/0  |  提交时间：2024/03/21 P2Y(12)inhibitor  pharmacodynamics  pharmacokinetics  vicagrel   Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing 期刊论文  OAI收割 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 卷号: 127, 页码: 151-160 作者:  Li, Cai;  Zhang, Yifan;  Chen, Weili;  Lu, Youming;  Li, Wei   |  收藏  |  浏览/下载：102/0  |  提交时间：2019/01/08 Vicagrel  Clopidogrel  P2Y(12) inhibitor  Pharmacokinetics  Active metabolite  Thienopyridine   Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers 期刊论文  OAI收割 FRONTIERS IN PHARMACOLOGY, 2018, 卷号: 9 作者:  Li, Xiaojiao;  Liu, Ca;  Zhu, Xiaoxue;  Wei, Haijing;  Zhang, Hong   |  收藏  |  浏览/下载：56/0  |  提交时间：2019/01/08 vicagrel  pharmacokinetics  pharmacodynamics  safety  clopidogrel   Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma 期刊论文  OAI收割 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 卷号: 149, 页码: 394-402 作者:  Liu, Cai;  Lu, Youming;  Sun, Hongbin;  Yang, Jin;  Liu, Yongqiang   |  收藏  |  浏览/下载：32/0  |  提交时间：2019/01/08 Vicagrel  Clopidogrel  Active metabolite  LC-MS/MS  Human plasma  P2Y(12) inhibitor   Arylacetamide Deacetylase Is Involved in Vicagrel Bioactivation in Humans 期刊论文  OAI收割 FRONTIERS IN PHARMACOLOGY, 2017, 卷号: 8 作者:  Jiang, Jinfang;  Chen, Xiaoyan;  Zhong, Dafang   |  收藏  |  浏览/下载：32/0  |  提交时间：2019/01/08 arylacetamide deacetylase  vicagrel  clopidogrel  hydrolytic metabolism   METABOLISM AND PHARMACOKINETICS OF VICAGREL, A NOVEL THIENOPYRIDINE P2Y12 INHIBITOR, COMPARED WITH CLOPIDOGREL IN HEALTHY CHINESE SUBJECTS 会议论文  OAI收割 作者:  Liu, Cai;  Chen, Xiaoyan;  Zhong, Dafang   |  收藏  |  浏览/下载：26/0  |  提交时间：2019/01/08 Human Liver Cytochrome P450 Enzymes and Microsomal Thiol Methyltransferase Are Involved in the Stereoselective Formation and Methylation of the Pharmacologically Active Metabolite of Clopidogrel 期刊论文  OAI收割 DRUG METABOLISM AND DISPOSITION, 2015, 卷号: 43, 期号: 10, 页码: 1632-1641 作者:  Liu, Cai;  Chen, Zhaoqiang;  Zhong, Kan;  Li, Liang;  Zhu, Weiliang   |  收藏  |  浏览/下载：26/0  |  提交时间：2019/01/08